Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Transdermal Fentanyl: Pharmacology and Toxicology
Journal of Medical Toxicology, 11/02/09
Nelson L et al. – Fentanyl is a high–potency opioid that has many uses in the treatment of both acute and chronic pain. Intentional or unintentional misuse, as well as abuse, may lead to significant clinical consequences, including death. Both the US Food and Drug Administration (FDA) and Health Canada have warned of potential pitfalls associated with transdermal fentanyl, although these have not been completely effective in preventing life–threatening adverse events and fatalities related to its inappropriate use. Clinically consequential adverse effects may occur unexpectedly with normal use of transdermal fentanyl, or if misused or abused. Misuse and therapeutic error may be largely preventable through better education at all levels for both the prescriber and patient. The prevention of intentional misuse or abuse may require regulatory intervention.
Related Articles
The Use of Transdermal Fentanyl in Cancer Pain: A Compliance Study of Outpatients in Taiwan
American Journal of Hospice and Palliative Medicine, 10/05/09
Relevance Score: 78%
Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
Current Medical Research and Opinion, 10/13/09
Relevance Score: 67%
Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Relevance Score: 65%
Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Covidien, 11/05/09
Relevance Score: 65%
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology, 10/20/09
Relevance Score: 64%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dermatomyositis: current and future treatments
Expert Review of Dermatology, 12/03/09
Rosiglitazone May Assist With Glycemic Control on the ICU
Journal of Intensive Care Medicine, 12/03/09
Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Sexual dysfunction in patients with fibromyalgia
Current Rheumatology Reports, 12/03/09
Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome
Scandinavian Journal of Urology and Nephrology, 12/03/09
A survey of general practitioners' assessment and management of shoulder pain: training and practice
International Musculoskeletal Medicine, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


